Quanterix to Present at Cowen’s 44th Annual Health Care Conference
February 23 2024 - 4:30PM
Business Wire
Quanterix Corporation (NASDAQ: QTRX), a company fueling
scientific discovery through ultrasensitive biomarker detection,
today announced that Chief Executive Officer Masoud Toloue will
present at Cowen’s 44th Annual Health Care Conference. Quanterix’s
session will take place on Monday, March 4, 2024, at 12:50 p.m. EST
and will be made available to attendees and, via webcast, the
general public. In addition to the session, Quanterix will also
host one-on-one meetings with institutional investors during the
conference.
Cowen’s 44th Annual Health Care Conference will take place March
4 - 6, 2024, in Boston, MA. The conference incorporates
presentations, fireside chats and panel discussions hosted by
members of the Cowen research team that focus on various aspects of
the health care industry.
Webcast Information To access the live audio webcast of
Quanterix’s presentation at the conference, please visit:
https://wsw.com/webcast/cowen154/qtrx/2067466. Quanterix’s session
will take place on Monday, March 4, 2024, at 12:50 p.m. EST.
Replays of the presentation will be available for a limited
period following the conference. The presentation will also be made
available through the Investor Relations section of Quanterix’s
website.
To learn more about Quanterix, visit www.quanterix.com/about. To
learn more about Quanterix’s Simoa® technology, visit:
www.quanterix.com/simoa-technology/.
About Quanterix From discovery to diagnostics,
Quanterix’s ultrasensitive biomarker detection is fueling
breakthroughs only made possible through its unparalleled
sensitivity and flexibility. The Company’s Simoa ® technology has
delivered the gold standard for earlier biomarker detection in
blood, serum or plasma, with the ability to quantify proteins that
are far lower than the Level of Quantification (LoQ). Its
industry-leading precision instruments, digital immunoassay
technology and CLIA-certified Accelerator laboratory have supported
research that advances disease understanding and management in
neurology, oncology, immunology, cardiology and infectious disease.
Quanterix has been a trusted partner of the scientific community
for nearly two decades, powering research published in more than
2,700 peer-reviewed journals. Find additional information about the
Billerica, Massachusetts-based company at https://www.quanterix.com
or follow us on Twitter and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240223277311/en/
Media Contact: PAN Communications Maya Nimnicht
510-334-6273 quanterix@pancomm.com
Investor Relations Contact: Amy Achorn (978) 488-1854
ir@quanterix.com
Quanterix (NASDAQ:QTRX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Quanterix (NASDAQ:QTRX)
Historical Stock Chart
From Oct 2023 to Oct 2024